The insufficient intracellular H₂O₂ level in tumor cells is closely associated with the limited efficacy of chemodynamic therapy (CDT). Despite tremendous efforts, engineering CDT agents with a straightforward and secure H₂O₂ supplying ability remains a great challenge. Inspired by the balance of H₂O₂ generation and elimination in cancer cells, herein, a nanozyme-based H₂O₂ homeostasis disruptor is fabricated to elevate the intracellular H₂O₂ level through facilitating H₂O₂ production and restraining H₂O₂ elimination for enhanced CDT. In the formulation, the disruptor with superoxide dismutase-mimicking activity can convert O₂•- to H₂O₂, promoting the production of H₂O₂. Simultaneously, the suppression of catalase activity and depletion of glutathione by the disruptor weaken the transformation of H₂O₂ to H₂O. Thus, the well-defined system could perturb the H₂O₂ balance and give rise to the accumulation of H₂O₂ in cancer cells. The raised H₂O₂ level would ultimately amplify the Fenton-like reaction-based CDT efficiency. Our work not only paves a way to engineer alternative CDT agents with a H₂O₂ supplying ability for intensive CDT but also provides new insights into the construction of bioinspired materials.
No takes yet. Share an insight, caveat, or question.
Sang et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: